Spray Venture Partners focuses exclusively on contributing capital and expertise to emerging healthcare technology companies.
Business Model:
Revenue: $6.3M
Employees: 2-10
Address: 2330 Washington St
City: Newton
State: MA
Zip: 02462
Country: US
Spray Venture Partners focuses exclusively on contributing capital and expertise to emerging healthcare technology companies. They work closely with clinical and technical founders to create companies that develop, market and deploy innovative technologies to meet major unmet healthcare needs.
Contact Phone:
+16173326060
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2013 | Conventus Orthopaedics | Venture Round | 0 |
1/2001 | Intrinsic Therapeutics | Series B | 7.2M |
8/2007 | Leptos Biomedical | Series C | 20M |
1/2011 | PneumRx | Venture Round | 0 |
1/2013 | Tryton Medical | Unattributed | 24M |
3/2007 | PneumRx | Series B | 0 |
6/2009 | Facet Solutions | Debt Financing | 4.1M |
6/2002 | Confluent Surgical | Series C | 20M |
10/2007 | Direct Flow Medical | Series B | 27M |
2/2010 | Intrinsic Therapeutics | Venture Round | 18M |
12/2005 | Facet Solutions | Series B | 16.5M |
10/2003 | Cotherix | Series C | 55M |
5/2010 | TearScience | Series C | 44.5M |
12/2002 | Intrinsic Therapeutics | Series C | 25M |
7/2009 | Interlace Medical | Series C | 20.5M |
9/2007 | Intrinsic Therapeutics | Series D | 21M |
4/2012 | Direct Flow Medical | Venture Round | 0 |
8/2006 | Interlace Medical | Series A | 750k |
1/2007 | TearScience | Series B | 15.1M |
3/2012 | Solace Therapeutics | Equity | 7M |
8/2006 | Solace Therapeutics | Series B | 3M |
4/2008 | Tryton Medical | Series C | 14M |
2/2004 | Facet Solutions | Series A | - |
10/2009 | Direct Flow Medical | Series C | 40M |
9/2010 | Tryton Medical | Series D | 20M |
5/2007 | Interlace Medical | Series B | 3M |
7/2008 | Interlace Medical | Series B | 7M |
3/2000 | Intrinsic Therapeutics | Series A | - |
7/2005 | TearScience | Series A | 100k |
8/2005 | Direct Flow Medical | Series A | 8.4M |
10/2013 | Conventus Orthopaedics | Venture Round | 0 |
1/2013 | Tryton Medical | Venture Round | 0 |
4/2012 | Direct Flow Medical | Venture Round | 0 |
3/2012 | Solace Therapeutics | Venture Round | 0 |
1/2011 | PneumRx | Venture Round | 0 |
9/2010 | Tryton Medical | Series D | 0 |
5/2010 | TearScience | Series C | 0 |
2/2010 | Intrinsic Therapeutics | Venture Round | 0 |
10/2009 | Direct Flow Medical | Series C | 0 |
7/2009 | Interlace Medical | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|